Skip to main content

Peer Review reports

From: Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010–2019 – a country with a national tender system for prescription of costly drugs

Original Submission
20 Oct 2021 Submitted Original manuscript
3 Nov 2021 Reviewed Reviewer Report
8 Nov 2021 Reviewed Reviewer Report
25 Nov 2021 Author responded Author comments - Alen Brkic
Resubmission - Version 2
25 Nov 2021 Submitted Manuscript version 2
15 Dec 2021 Editorially accepted
10 Jan 2022 Article published 10.1186/s12913-021-07425-w

You can find further information about peer review here.

Back to article page